Zimmer Biomet Announces Second Quarter 2026 Financial Results
Article excerpt
Highlighted: the sentence this signal was extracted from
WARSAW, Ind., Aug. 5, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) and (SIX: ZBH) today reported financial results for the quarter ended June 30, 2026. The Company reported second quarter net sales of $2.177 billion, an increase of 4.8% over the prior year period, an increase of 4.7% on a constant currency 1 basis and an increase of 4.0% on an organic constant currency 1 basis. Net earnings for the second quarter were $198.3 million, or $399.6 million on an adjusted 1 basis. Diluted earnings per share were $1.03 for the second quarter, an increase of 33.8%, and adjusted 1 diluted earnings per share were $2.07, consistent with the prior year period. Zimmer Biomet generated $447.9 million in operating cash flow and $308.3 million of free cash flow 1 in the second quarter. 1 Reconciliations of these measures to the corresponding U.S. generally accepted accounting principles measures are included in this press release. "We delivered strong second quarter results with solid top- and bottom-line performance and continued progress on our key growth drivers and commercial transformation," said Ivan Tornos, Chairman, President and CEO of Zimmer Biomet. "With a strong first half, healthy underlying markets, go-to-market changes progressing as planned and continued momentum from our innovation cycle, we are raising our revenue and adjusted EPS guidance for the year...
Keep reading with a free account
The rest of this article, and every signal for Zimmer Biomet, is in your free account.
